AOXG OTC
Aoxing Pharmaceutical Company, Inc.
1W: +0.0%
1M: +4.8%
3M: -46.3%
YTD: -62.7%
1Y: -68.6%
3Y: +120.0%
5Y: -85.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±60.0%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$103K
+0.0% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$103K
+0.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$14K
+0.0% ▲
Net Change in Cash
-$21K
+0.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2013 | FY2014 | FY2015 | FY2023 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$8M | $5M | $2M | -$15K | -$23K |
| Depreciation & Amort. | $990K | $666K | $1M | $0 | $0 |
| Stock-Based Comp. | $19K | $170 | $289 | $0 | $0 |
| Change in Working Capital | -$1M | -$805K | -$6M | $15K | -$80K |
| Other Non-Cash Items | -$419K | $494K | $471K | -$15K | $0 |
| Operating Cash Flow | -$8M | $3M | -$535K | -$15K | -$103K |
| — Investing Activities — | |||||
| Capital Expenditures | -$269K | -$3M | -$118K | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$269K | -$3M | -$118K | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | -$5M | $249K | $207K | $0 | $96K |
| Stock Repurchased | $0 | $0 | $0 | $0 | -$14K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $12M | $0 | $0 | $15K | $0 |
| Financing Cash Flow | $6M | $3M | $3M | $15K | $82K |
| Net Change in Cash | -$2M | $3M | $2M | $0 | -$21K |
| Cash End of Period | $2M | $5M | $7M | $0 | $5K |
| Free Cash Flow | -$8M | $320K | -$653K | -$15K | -$103K |